105 related articles for article (PubMed ID: 9340574)
1. [Characteristics of apolipoprotein polymorphism in a Hungarian population].
Császár A
Orv Hetil; 1997 Sep; 138(36 Suppl 2):2296-7. PubMed ID: 9340574
[TBL] [Abstract][Full Text] [Related]
2. [Clinical manifestations of familial hypercholesterolemia in Mediterranean population].
Alonso-Villaverde C; Sardà P; Vallbé JC; Heras M; Pérez-Jiménez F; Pedro-Botet JC; Ros-Rahola E; Masana L
Med Clin (Barc); 1999 Oct; 113(14):521-5. PubMed ID: 10605666
[TBL] [Abstract][Full Text] [Related]
3. [The apolipoprotein AII gene is not a risk factor for development ischemic heart disease in the Moscow population].
Shadrina MI; Slominskiĭ PA; Perova NV; Limborskaia SA
Genetika; 1997 Sep; 33(9):1316-8. PubMed ID: 9445826
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B gene polymorphisms in people in the east Mediterranean area of Turkey.
Tamer L; Tanriverdi K; Ercan B; Unlu A; Sucu N; Pekdemir H; Atik U
East Mediterr Health J; 2004; 10(1-2):125-30. PubMed ID: 16201717
[TBL] [Abstract][Full Text] [Related]
5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
6. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of lipid metabolism disorders in blood donors].
Uhlig R; Köhler P; Pissarek D; Bischoff I
Z Gesamte Inn Med; 1980 Feb; 35(3):141-4. PubMed ID: 7395296
[TBL] [Abstract][Full Text] [Related]
8. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
9. Future genetic-epidemiological research in coronary heart disease: the decade of the apolipoproteins, dysapolipoproteinemia, and dyslipoproteinemia.
Glueck CJ
Prog Clin Biol Res; 1984; 147():525-32. PubMed ID: 6377319
[No Abstract] [Full Text] [Related]
10. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
Kronenberg F; Auinger M; Dieplinger H
Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
[TBL] [Abstract][Full Text] [Related]
11. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
Frikke-Schmidt R
Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
[TBL] [Abstract][Full Text] [Related]
12. Clinical disorders of lipoprotein metabolism.
Brewer HB; Gregg RE; Hoeg JM; Law S
Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
[No Abstract] [Full Text] [Related]
13. [Detection and treatment of lipid disorders].
Barraquer Bordas L
Rev Clin Esp; 1988 Nov; 183(8):427-32. PubMed ID: 3222513
[No Abstract] [Full Text] [Related]
14. [Genetics in ischaemic heart disease].
Wojtczak A; Skretkowicz J
Pol Merkur Lekarski; 2007 Jul; 23(133):5-8. PubMed ID: 18051822
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and prognostic significance of major risk factors and some reproductive system changes in the development of atherosclerosis and ischemic heart disease in women of child-bearing age].
Emel'ianova LA; Tsybulina EV; Zharkin AF
Ter Arkh; 2000; 72(9):27-33. PubMed ID: 11076412
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
Liberopoulos E; Miltiadous G; Hatzivassiliou M; Ayrton N; Bairaktari E; Cariolou M; Elisaf M
Ann Clin Lab Sci; 2004; 34(3):347-54. PubMed ID: 15487712
[TBL] [Abstract][Full Text] [Related]
17. [Hypercholesterolaemia among patients of the cardiology ward of a Regional Hospital in Wejherowo].
Grunholz E; Rybakowska I; Anand JS; Chodorowski Z; Waldman W; Kaletha K
Przegl Lek; 2009; 66(6):354-5. PubMed ID: 19788150
[TBL] [Abstract][Full Text] [Related]
18. [Changes of blood lipids and apolipoproteins in patients with silent myocardial ischemia].
Tan M; Zhao S; Yu S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):44-6, 56. PubMed ID: 10681793
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the C242T polymorphism of NAD(P)H oxidase p22 phox gene and ischaemic heart disease using family-based association methods.
Spence MS; McGlinchey PG; Patterson CC; Allen AR; Murphy G; Bayraktutan U; Fogarty DG; Evans AE; McKeown PP
Clin Sci (Lond); 2003 Dec; 105(6):677-82. PubMed ID: 12877653
[TBL] [Abstract][Full Text] [Related]
20. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
